More recently, rocaglamide, a natural anticancer compound derived from the traditional Chinese medicinal plant Aglaia, has been shown to selectively bind to PHB protein with nanomolar affinity in human cervical cancer cell line HeLa and human T cell leukemic cell line Jurkat. The gene discussed is PHB1; the disease is cervical carcinoma.